See more : MeiHua Holdings Group Co.,Ltd (600873.SS) Income Statement Analysis – Financial Results
Complete financial analysis of TINAVI Medical Technologies Co., Ltd. (688277.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TINAVI Medical Technologies Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Top Strike Resources Corp. (TPPRF) Income Statement Analysis – Financial Results
- Séché Environnement SA (SCHP.PA) Income Statement Analysis – Financial Results
- James Hardie Industries plc (JHX) Income Statement Analysis – Financial Results
- Suncorp Technologies Limited (1063.HK) Income Statement Analysis – Financial Results
- Poko Innovations Inc. (POKO.CN) Income Statement Analysis – Financial Results
TINAVI Medical Technologies Co., Ltd. (688277.SS)
About TINAVI Medical Technologies Co., Ltd.
TINAVI Medical Technologies Co., Ltd. engages in the research and development, production, and clinical application of orthopedic robotic systems. It offers TiRobot, an orthopedic robotic system used in orthopedic surgeries for spine and trauma. The company was founded in 2010 and is based in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 210.04M | 156.19M | 156.02M | 135.91M | 229.56M | 126.72M | 73.29M | 25.58M | 23.98M | 38.77M | 41.76M |
| Cost of Revenue | 60.61M | 53.64M | 49.95M | 31.27M | 34.56M | 30.26M | 24.03M | 13.63M | 12.93M | 29.76M | 19.72M |
| Gross Profit | 149.42M | 102.55M | 106.07M | 104.64M | 195.01M | 96.46M | 49.26M | 11.95M | 11.04M | 9.01M | 22.04M |
| Gross Profit Ratio | 71.14% | 65.66% | 67.98% | 76.99% | 84.95% | 76.12% | 67.21% | 46.72% | 46.05% | 23.23% | 52.79% |
| Research & Development | 140.32M | 122.64M | 109.79M | 74.11M | 77.01M | 41.49M | 22.29M | 16.33M | 14.49M | 10.29M | 9.95M |
| General & Administrative | 30.90M | 21.21M | 12.45M | 23.09M | 41.71M | 16.91M | 4.88M | 16.41M | 25.11M | 24.13M | 22.35M |
| Selling & Marketing | 78.29M | 91.40M | 71.42M | 66.25M | 86.46M | 39.88M | 22.36M | 15.27M | 10.30M | 3.55M | 3.24M |
| SG&A | 109.19M | 112.61M | 83.87M | 89.35M | 128.16M | 56.79M | 27.24M | 31.68M | 36.89M | 27.68M | 25.59M |
| Other Expenses | 50.31M | 13.68M | 15.93M | 12.38M | 34.62M | 98.69K | 3.07M | 8.27M | 0.00 | 6.42M | 13.38M |
| Operating Expenses | 296.31M | 248.92M | 209.59M | 175.85M | 239.80M | 86.44M | 41.66M | 48.57M | 28.55M | 28.75M | 26.04M |
| Cost & Expenses | 360.44M | 302.56M | 259.54M | 207.11M | 274.35M | 116.70M | 65.70M | 62.20M | 41.48M | 58.52M | 45.76M |
| Interest Income | 2.78M | 1.36M | 5.79M | 1.62M | 459.47K | 989.76K | 77.47K | 0.00 | 2.06M | 0.00 | 0.00 |
| Interest Expense | 6.43M | 3.95M | 3.35M | 62.54K | 71.62K | 162.63K | 28.41K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 44.72M | 50.16M | 41.61M | 16.87M | 15.28M | 5.98M | 1.95M | 1.72M | 360.11K | 2.37M | 2.02M |
| EBITDA | -102.68M | -87.15M | -59.64M | -51.47M | -27.49M | -1.72M | 17.70M | -34.90M | -26.13M | -17.37M | -1.98M |
| EBITDA Ratio | -48.88% | -63.11% | -38.83% | -45.12% | -15.30% | 16.03% | 12.93% | -136.02% | -108.98% | -43.83% | -2.30% |
| Operating Income | -149.43M | -146.37M | -103.52M | -71.20M | -44.79M | -8.09M | 12.65M | -32.99M | -26.49M | -20.58M | -5.23M |
| Operating Income Ratio | -71.14% | -93.71% | -66.35% | -52.39% | -19.51% | -6.38% | 17.26% | -128.98% | -110.48% | -53.08% | -12.53% |
| Total Other Income/Expenses | -322.50K | -226.62K | -169.81K | -4.26M | -3.38M | 98.69K | 3.07M | 8.27M | 9.00M | 6.42M | 13.38M |
| Income Before Tax | -149.75M | -144.16M | -104.65M | -68.40M | -42.84M | -7.99M | 15.72M | -24.72M | -15.45M | -14.16M | 8.15M |
| Income Before Tax Ratio | -71.30% | -92.30% | -67.08% | -50.33% | -18.66% | -6.31% | 21.45% | -96.65% | -64.44% | -36.52% | 19.51% |
| Income Tax Expense | 10.61M | -31.82M | -22.00M | -14.23M | -8.68M | -4.33M | -5.56M | 106.60K | 0.00 | 1.60M | 1.84M |
| Net Income | -156.39M | -112.34M | -82.65M | -54.16M | -34.17M | -855.98K | 21.67M | -24.72M | -15.45M | -15.76M | 6.31M |
| Net Income Ratio | -74.46% | -71.92% | -52.97% | -39.85% | -14.88% | -0.68% | 29.56% | -96.65% | -64.44% | -40.66% | 15.10% |
| EPS | -0.35 | -0.27 | -0.20 | -0.13 | -0.08 | 0.00 | 0.07 | -0.08 | -0.10 | -0.52 | 0.21 |
| EPS Diluted | -0.35 | -0.27 | -0.20 | -0.13 | -0.08 | 0.00 | 0.07 | -0.08 | -0.10 | -0.52 | 0.21 |
| Weighted Avg Shares Out | 446.82M | 419.85M | 419.85M | 418.44M | 418.44M | 309.56M | 309.56M | 309.00M | 154.50M | 30.31M | 30.03M |
| Weighted Avg Shares Out (Dil) | 446.82M | 419.85M | 419.85M | 418.44M | 418.44M | 309.56M | 309.56M | 309.00M | 154.50M | 30.31M | 30.03M |
Source: https://incomestatements.info
Category: Stock Reports